Latham & Watkins advised De Nora, while White & Case advised a group of lenders on the transaction. The lenders granded a €200 million credit facility to...
Industrie De Nora And De Nora Holdings US’s €200 Million And $100 Million Financing
MaxLinear’s $3.8 Billion Take-Private Acquisition of Silicon Motion
Latham & Watkins and K&L Gates advised Silicon Motion on the transaction, while Wilson Sonsini Goodrich & Rosati advised MaxLinear. MaxLinear, Inc. (NASDAQ: MXL), a California-based...
Group14 Technologies’ $400 Million Series C Funding Round
Latham & Watkins advised OMERS Capital Markets on the transaction while Vinson & Elkins advised an affiliate of Riverstone Holdings LLC. Group14 Technologies, a global manufacturer...
Point’s $115 Million Series C Financing
Latham & Watkins represented Point in the transaction. Point, a fintech company and home equity platform that provides homeowners access to equity financing in exchange for...
Astorg’s Acquisition of CordenPharma
Freshfields Bruckhaus Deringer has advised International Chemical Investors Group on the deal, while Walder Wyss and Latham & Watkins advised Astorg. Milbank advised the management of...
Lagardère’s Amendment of its Revolving Credit Facility
Allen & Overy has advised the syndicate of lending banks in connection with the extension and amendment of the Lagardère SA group’s revolving credit facility, while...
SmileDirectClub’s $255 Million Debt Facility
Latham & Watkins represented the lender, HPS Investment Partners, in the transaction. SDC US SmilePay SPV’s (SPV), a wholly-owned special purpose subsidiary of SmileDirectClub, Inc. announced...
Origis Energy’s $375 Million Credit Facility for Solar and Energy Storage Development Pipeline
Latham and Watkins represented Origis Energy in the transaction. Norton Rose Fulbright acted as lender counsel. Origis Energy, one of America’s leading renewable energy platforms, announced...
Xepelin’s $111 Million Series B Financing
Gunderson Dettmer represented Xepelin on the deal. Latham & Watkins and Barros & Errázuriz and Ritch, Mueller y Nicolau represented Avenir. Carey advised Manutara Ventures and...
HilleVax’s $200 Million Initial Public Offering
Latham & Watkins represented HilleVax, while Davis Polk advised the joint book-running managers in the IPO. HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and...
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
VistaJet Malta Finance’s $500 Million Senior Notes Offering
Latham & Watkins represented VistaJet in the offering. VistaJet Malta Finance P.L.C., a public limited liability company organized under Maltese law and XO Management Holding, Inc.,...